news
El Financiero
2026-10-23
Doctors praise Moderna's melanoma vaccine despite Wall Street sell-off
Medical experts are optimistic about clinical trial results showing Moderna's vaccine reduces melanoma recurrence by 42%, even as company stocks dropped on Wall Street.